Study of the Follow-up of Stroke Treated With Anticoagulants

Completed

• Conditions: Stroke
• Interventions: Drug: Anticoagulants

• Registration Number: NCT03292575
• Lead Sponsor: Centre Hospitalier Universitaire Dijon

Brief Summary

Stroke is a major public health problem as it is very frequent (140,000 cases/year in France), and very serious (leading cause of death, 2nd leading cause of dementia, 3rd leading cause of handicap). Ischemic cardio-embolic stroke accounts for around 25% of ischemic strokes, and ischemic cardio-embolic stroke in a context of cardiac arrhythmia due to atrial fibrillation (CAAF) is the leading non-atheromatous cause. The aim of this study is to optimise the secondary prevention of CAAF-related stroke identified at the University Hospital of Dijon Burgundy in the framework of the recommendations of the '2010-2014 stroke plan' and the Compulsory Consultation at the 6th month (Directive DGOS//2015/262 of the 3rd August 2015)

Detailed Description

Not available

Study Timeline

• Study Start: 2016-01
• Study First Submitted: 2017-09-21
• Study First Submitted QC: 2017-09-21
• Study First Posted: 2017-09-25
• Primary Completion: 2018-12
• Study Completion: 2018-12
• Status Verified: 2019-06
• Last Update Submitted: 2019-06-03
• Last Update Posted: 2019-06-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 441

Inclusion Criteria

• patients managed for stroke at the stroke unit of Dijon University Hospital for CAAF-related cardio-embolic stroke

Exclusion Criteria

• NA

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Stroke related to CAAF	Anticoagulants	-

Primary Outcome Measures

Name	Time	Method
rate of stroke recurrences	12 months after inclusion

Trial Locations

Locations (1)

CHU Dijon Bourgogne; 🇫🇷 Dijon, France